Alyeska Investment Group
TXG icon

Alyeska Investment Group’s 10x Genomics TXG Stock Holding History

Alyeska Investment Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-706,492
Closed -$26.5M – 676
2024
Q1 		$26.5M Sell
706,492
-2,357
-0.3% -$104K 0.16% 184
2023
Q4 		$39.7M Sell
708,849
-10,473
-1% -$456K 0.26% 120
2023
Q3 		$29.7M Buy
+719,322
New +$37.4M 0.2% 164
2020
Q2 		– Sell
-107,339
Closed -$6.69M – 573
2020
Q1 		$6.69M Buy
+107,339
New +$8.38M 0.13% 164
2019
Q4 		– Sell
-50,177
Closed -$2.53M – 494
2019
Q3 		$2.53M Buy
+50,177
New +$2.78M 0.04% 278

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Alyeska Investment Group's TXG Position: Q2 2024 in Review

Alyeska Investment Group sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 706,492 shares — an estimated $26.5M sold.

Alyeska Investment Group first reported a position in TXG in Q3 2019 and held it in 5 quarters. The position peaked at $39.7M in Q4 2023. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Alyeska Investment Group reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 706,492 10x Genomics shares in Q2 2024, an estimated $26.5M.
  • Alyeska Investment Group first reported a position in 10x Genomics in Q3 2019 and held it in 5 quarters.
  • Alyeska Investment Group's 10x Genomics position peaked at $39.7M in Q4 2023.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Alyeska Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.